Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBAVIRIN Cause Multiple organ dysfunction syndrome? 64 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Multiple organ dysfunction syndrome have been filed in association with RIBAVIRIN (Ribavirin). This represents 0.2% of all adverse event reports for RIBAVIRIN.

64
Reports of Multiple organ dysfunction syndrome with RIBAVIRIN
0.2%
of all RIBAVIRIN reports
62
Deaths
40
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From RIBAVIRIN?

Of the 64 reports, 62 (96.9%) resulted in death, 40 (62.5%) required hospitalization, and 5 (7.8%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBAVIRIN. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does RIBAVIRIN Cause?

Fatigue (5,565) Anaemia (5,130) Nausea (4,434) Headache (3,497) Rash (2,686) Insomnia (2,653) Pruritus (2,490) Pyrexia (2,487) Drug ineffective (2,364) Vomiting (2,280)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which RIBAVIRIN Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

RIBAVIRIN vs RIBOCICLIB RIBAVIRIN vs RIBOFLAVIN RIBAVIRIN vs RIBOFLAVIN 5'-PHOSPHATE RIBAVIRIN vs RIBOFLAVIN 5^-PHOSPHATE RIBAVIRIN vs RIFABUTIN

Related Pages

RIBAVIRIN Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome RIBAVIRIN Demographics